Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgELinda Cox, Robert K. Zeldin, Peter S. Creticos et al.|Journal of Allergy and Clinical Immunology|2012Cited by 133
Tolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitis.Anjuli Nayak, Niroo Gupta, Thomas B. Casale et al.|PubMed|2004Cited by 45